Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Gomeni

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Anti-Cancer Drugs|June 5, 2002
A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancerAmélie Gauvin, Frédéric Pinguet, Stéphane Culine, et al.
Journal of Clinical Pharmacology|October 20, 2015
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use DisorderCeline M Laffont, Roberto Gomeni, Christian Heidbreder, et al.
Clinical Pharmacology and Therapeutics|August 10, 2019
Model-Informed Approach to Assess the Treatment Effect Conditional to the Level of Placebo ResponseRoberto Gomeni, Jonathan Rabinowitz, Navin Goyal, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2014
Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment resistant patientsSteven D Targum, Daniel J Burch, Mahnaz Asgharnejad, et al.
Anesthesiology|September 10, 2003
Pharmacokinetics of propofol administered by target-controlled infusion to alcoholic patientsFrédérique S Servin, Bernard Bougeois, Roberto Gomeni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Modeling Alzheimer's disease progression using the disease system analysis approachRoberto Gomeni, Monica Simeoni, Marina Zvartau-Hind, et al.
Oncology Research|March 28, 2003
Modeling plasma and saliva topotecan concentration time course using a population approachMaud Boucaud, Frédéric Pinguet, Stéphane Culine, et al.
Clinical Pharmacology in Drug Development|March 22, 2022
Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed-Release and Extended-Release Methylphenidate: In Vivo, In Vitro, and Modeling EvaluationsBev Incledon, Chantal Incledon, Roberto Gomeni, et al.
Clinical Pharmacokinetics|July 13, 2014
A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependenceAzmi F Nasser, Christian Heidbreder, Roberto Gomeni, et al.
Clinical Pharmacokinetics|January 28, 2014
Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatmentCeline M Laffont, Roberto Gomeni, Bo Zheng, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Anti-Cancer Drugs|June 5, 2002
A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancerAmélie Gauvin, Frédéric Pinguet, Stéphane Culine, et al.
Journal of Clinical Pharmacology|October 20, 2015
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use DisorderCeline M Laffont, Roberto Gomeni, Christian Heidbreder, et al.
Clinical Pharmacology and Therapeutics|August 10, 2019
Model-Informed Approach to Assess the Treatment Effect Conditional to the Level of Placebo ResponseRoberto Gomeni, Jonathan Rabinowitz, Navin Goyal, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2014
Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment resistant patientsSteven D Targum, Daniel J Burch, Mahnaz Asgharnejad, et al.
Anesthesiology|September 10, 2003
Pharmacokinetics of propofol administered by target-controlled infusion to alcoholic patientsFrédérique S Servin, Bernard Bougeois, Roberto Gomeni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Modeling Alzheimer's disease progression using the disease system analysis approachRoberto Gomeni, Monica Simeoni, Marina Zvartau-Hind, et al.
Oncology Research|March 28, 2003
Modeling plasma and saliva topotecan concentration time course using a population approachMaud Boucaud, Frédéric Pinguet, Stéphane Culine, et al.
Clinical Pharmacology in Drug Development|March 22, 2022
Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed-Release and Extended-Release Methylphenidate: In Vivo, In Vitro, and Modeling EvaluationsBev Incledon, Chantal Incledon, Roberto Gomeni, et al.
Clinical Pharmacokinetics|July 13, 2014
A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependenceAzmi F Nasser, Christian Heidbreder, Roberto Gomeni, et al.
Clinical Pharmacokinetics|January 28, 2014
Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatmentCeline M Laffont, Roberto Gomeni, Bo Zheng, et al.
Pageof 8